Shape Therapeutics
Company Type: Therapeutic development
Main focus: Combining AI and RNA-editing technology to develop novel treatments for genetic diseases
Company stage: Pre-clinical
Diseases: Rett syndrome, Parkinson’s disease, and Alzheimer’s disease
Genome-editing tool: Proprietary RNA-editing platform RNAfix®
Funding stage: Series B
Location: Seattle, Washington, USA
Website: https://shapetx.com/
Pipeline:
Partners:
Shape Therapeutics (Shape TX) is a biotechnology company based in Seattle and Boston. The company aims to develop novel therapeutics to treat various diseases through RNA editing. Through merging the power of AI and RNA-editing technology, Shape TX aims to develop programmable RNA-editing treatments to correct the genetic causes of diseases.